HPV Vaccine’s Protective Reach Extends to Men, Reducing Head and Neck Cancers
TL;DR Summary
An observational US study finds that the HPV vaccine, originally aimed at preventing cervical cancer in women, is associated with about a 70% lower incidence of head and neck cancers in men, especially oropharyngeal cancer. While not yet proving causation, the data suggest broad cancer-prevention benefits and reinforce the push for gender-neutral HPV vaccination beyond protecting cervical cancer.
- Cancer Vaccine Designed For Women Is Protecting a Surprising Amount of Men, Too ScienceAlert
- Studies provide more evidence that HPV vaccines benefit men CIDRAP
- The Wright Medicine: HPV vaccine critical in fight against infectious disease, cancer Scranton Times-Tribune
- Dispelling myths, misconceptions surrounding HPV vaccination for young women Deccan Herald
- HPV vaccination may reduce the risk of head and neck cancer in both women and men. GIGAZINE
Reading Insights
Total Reads
0
Unique Readers
18
Time Saved
8 min
vs 9 min read
Condensed
96%
1,652 → 58 words
Want the full story? Read the original article
Read on ScienceAlert